Kirsten Storch

Technical Considerations for Use of Oligonucleotide Solution API

Jale Müslehiddinoğlu, Robert Simler, Malcolm L. Hill et al. · Nucleic Acid Therapeutics · 2020 · 37 citations · Full text

Pharmacy, Pharmaceutics, Lyophilization +14

Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity

Stefan Fischer, Heike K. Wentsch, Svenja Mayer‐Wrangowski et al. · Journal of Medicinal Chemistry · 2012 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Metabolically Stable Dibenzo[<i>b</i>,<i>e</i>]oxepin-11(6<i>H</i>)-ones as Highly Selective p38 MAP Kinase Inhibitors: Optimizing Anti-Cytokine Activity in Human Whole Blood

Benjamin Baur, Kirsten Storch, Kathrin E. Martz et al. · Journal of Medicinal Chemistry · 2013 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Development of stable liquid formulations for oligonucleotides

Johanna Poecheim, Kirsten Gräeser, Joerg Hoernschemeyer et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2018 · 14 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +12